Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impact of genetic polymorphism on personalized diet and exercise program for steatotic liver disease. | Hepatol Res | 2024 | 37715600 | PubTator, text mining | PubMed |
| Impact of PNPLA3 I148M on alpha-1 antitrypsin deficiency-dependent liver disease progression. | Hepatology | 2024 | 37625151 | PubTator, text mining | PubMed |
| Genetic and Metabolic Characteristics of Lean Nonalcoholic Fatty Liver Disease in a Korean Health Examinee Cohort. | Gut Liver | 2024 | 37560798 | PubTator, text mining | PubMed |
| Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decades. | Dig Liver Dis | 2024 | 37507284 | PubTator, text mining | PubMed |
| No association of NAFLD-related polymorphisms in PNPLA3 and TM6SF2 with all-cause and cardiovascular mortality in an Austrian population study. | Wien Klin Wochenschr | 2024 | 37103556 | PubTator, text mining | PubMed |
| Genotype-informed nutrition counselling in clinical practice. | BMJ Nutr Prev Health | 2023 | 38618528 | PubTator, text mining | PubMed |
| Regional variation in NAFLD prevalence and risk factors among people living with HIV in Europe: a meta-analysis. | Front Public Health | 2023 | 38259755 | PubTator, text mining | PubMed |
| NASH/NAFLD-Related Hepatocellular Carcinoma: An Added Burden. | Life (Basel) | 2023 | 38255641 | PubTator, text mining | PubMed |
| A genomic and bioinformatic-based approach to identify genetic variants for liver cancer across multiple continents. | Genomics Inform | 2023 | 38224715 | PubTator, text mining | PubMed |
| Clinical Management of Non-alcoholic Steatohepatitis and the Role of the Cardiologist. | Eur Cardiol | 2023 | 38213666 | PubTator, text mining | PubMed |
| Predicting the Structural Impact of Human Alternative Splicing. | bioRxiv | 2023 | 38187531 | PubTator, text mining | PubMed |
| Association of MBOAT7 rs641738 polymorphism with hepatocellular carcinoma susceptibility: A systematic review and meta-analysis. | World J Gastrointest Oncol | 2023 | 38173430 | PubTator, text mining | PubMed |
| Risk factors of hepatocellular carcinoma in non-alcoholic fatty liver disease: a systematic review and meta-analysis. | Eur Rev Med Pharmacol Sci | 2023 | 38164853 | PubTator, text mining | PubMed |
| [Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review]. | Ter Arkh | 2023 | 38158911 | PubTator, text mining | PubMed |
| A Review of Incidence and Related Risk Factors in the Development of Hepatocellular Carcinoma. | Cureus | 2023 | 38149129 | PubTator, text mining | PubMed |
| Causal effects of non-alcoholic fatty liver disease on osteoporosis: a Mendelian randomization study. | Front Endocrinol (Lausanne) | 2023 | 38149094 | PubTator, text mining | PubMed |
| MASLD treatment-a shift in the paradigm is imminent. | Front Med (Lausanne) | 2023 | 38146424 | PubTator, text mining | PubMed |
| Hepatocyte-targeted siTAZ therapy lowers liver fibrosis in NASH diet-fed chimeric mice with hepatocyte-humanized livers. | Mol Ther Methods Clin Dev | 2023 | 38144682 | PubTator, text mining | PubMed |
| Impact of Combination Antiretroviral Treatment on Liver Metabolic Health in HIV-Infected Persons. | Viruses | 2023 | 38140673 | PubTator, text mining | PubMed |
| Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis. | Biomedicines | 2023 | 38137330 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=25